Our products, which include proprietary features and system specific instruments, have earned multiple awards, garnered positive feedback from the marketplace, and have remained within existing parameters for today’s current reimbursement codes. From company websiteSource · Oct 13, 2026
FDA FDA 510(k) clearance: SIros-X System — K252322, Oct 22, 2025. Applicant at approval: Genesys Spine. source ↗
FDA FDA 510(k) clearance: Genesys Spine AIS-C II Cervical Interbody Fusion System — K242483, Feb 7, 2025. Applicant at approval: Genesys Spine. source ↗
FDA records (last 2 years)
FDA 510(k) clearance: SIros-X System — K252322, Oct 22, 2025. Applicant at approval: Genesys Spine. source ↗
FDA 510(k) clearance: Genesys Spine AIS-C II Cervical Interbody Fusion System — K242483, Feb 7, 2025. Applicant at approval: Genesys Spine. source ↗
